ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.45253
2.72%
Brent Oil
81.205
0.50%
Bitcoin
68,900.00
1.70%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/06/202406:00Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CLNNWClene Inc
03/06/202406:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ODVWZOsisko Development Corporation
03/06/202406:00GlobeNewswire Inc.ATHA Energy Commences 2024 Angilak Diamond Drilling Exploration ProgramTG:X5UATHA Energy Corp
03/06/202406:00GlobeNewswire Inc.University of Rochester’s Eastman School of Music Recognized in the QS World University Rankings
03/06/202406:00Business WireBPGbio Appoints Biopharma Industry Leader Scott Minick to Board of Directors
03/06/202406:00Business WireInnoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:INVAInnoviva Inc
03/06/202406:00Business WireQuince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex SystemNASDAQ:QNCXQuince Therapeutics Inc
03/06/202406:00Business WireCalidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual MeetingAMEX:CLDICalidi Biotherapeutics Inc
03/06/202406:00Business WireAir Industries Group Reports Amendment to Loan Agreement with Webster BankAMEX:AIRIAir Industries Group
03/06/202406:00Business WireD-Wave Quantum Featured in Fireside Chat at Needham Technology, Media and Consumer ConferenceNYSE:QBTSD Wave Quantum Inc
03/06/202406:00Business WireModernFi Announces Integration with Q2's Digital Banking Platform
03/06/202406:00Business WireGreenbriar Equity Group Announces Acquisition of Renuity
03/06/202406:00Business WireBicycle Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:BCYCBicycle Therapeutics PLC
03/06/202406:00Business WireProPetro Acquires Aqua Prop, an Innovative Wet Sand Solutions ProviderNYSE:PUMPProPetro Holding Corp
03/06/202406:00Business WireMavenir, Qualcomm and EchoStar Achieve Industry-First 5G Open RAN RedCap Demonstration on the Boost Mobile Network
03/06/202406:00Business WireSpruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024NASDAQ:SPRBSpruce Biosciences Inc
03/06/202406:00Business WireTuring Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting
03/06/202406:00Business WireConsor Holdings Announces Growth Investment from New Mountain Capital
03/06/202406:00Business WireDeciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting and Online Publication in The LancetNASDAQ:DCPHDeciphera Pharmaceuticals Inc
03/06/202406:00Business WireGraham Corporation Receives $17 Million of Orders to Support Energy and Petrochemical Expansion Projects in North America and the Middle EastNYSE:GHMGraham Corp
03/06/202406:00Business WireIndiva Provides Update on SNDL Loan and Strategic ReviewTSXV:NDVAIndiva Ltd
03/06/202406:00Business WireBruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied LaboratoriesNASDAQ:BRKRBruker Corporation
03/06/202406:00Business WireRockwell Automation to Advance Intelligent Automation, Mobile Robotics in Manufacturing Logistics in Collaboration with NVIDIANYSE:ROKRockwell Automation Inc
03/06/202406:00Business WireBruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) ApplicationsNASDAQ:BRKRBruker Corporation
03/06/202406:00Business WireInternational Energy Forum Report Details EV Copper HurdlesNYSE:GENMGenter Capital Municipal Quality Intermediate ETF
03/06/202406:00Business WirePershing Square Capital Management, L.P. Announces Sale of 10% Common Equity Interest for $1.05 Billion to Strategic Investors
03/06/202406:00Business WireXeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024NASDAQ:XERSXeris Biopharma Holdings Inc
03/06/202406:00Business WireFormer DOJ Section Chief and Big Law Partner Opens Solow, PLLC
03/06/202406:00Business WirePershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors
03/06/202406:00Business WireBausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesNYSE:BLCOBausch plus Lomb Corporation

Su Consulta Reciente

LSE
FB58
Tor.dom.24
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados